Bruker Corporation (BRKRP) vs Caris Life Sciences, Inc. (CAI)
A side-by-side comparison of Bruker Corporation and Caris Life Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRKRP
Bruker Corporation
$451.00HealthcareDelayed quote: Oct 6, 2026, 11:58 AM EDT
CAI
Caris Life Sciences, Inc.
$28.05HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — BRKRP vs CAI
growth of $100 · dividends reinvested · last 1yBRKRP +94.8% (+94.8%/yr)CAI -16.4% (-16.4%/yr)BRKRP compounded faster over this window
BRKRP CAI
BRKRP vs CAI: by the numbers
- •BRKRP is the larger company ($9.05B vs $7.93B market cap).
- •CAI is profitable (10.62% net margin) while BRKRP runs a net loss (-2.03%).
- •CAI grew revenue faster over the past five years (26.15% vs 9.10% CAGR).
- •BRKRP pays a dividend (3.35% yield), while CAI has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BRKRP | CAI |
|---|---|---|
| P/E ratio | N/A | 78.37 |
| Forward P/E | 212.53 | 241.75 |
| P/S ratio | 2.59 | 8.01 |
| P/B ratio | 3.77 | 13.40 |
| EV / EBITDA | 30.23 | 44.19 |
| FCF yield | 1.04% | 1.85% |
Profitability
| Metric | BRKRP | CAI |
|---|---|---|
| Gross margin | 46.69% | 69.66% |
| Operating margin | 3.61% | 5.56% |
| Net margin | -2.03% | 10.62% |
| ROE | -2.97% | 17.77% |
| ROIC | 2.56% | 14.76% |
Dividends
| Metric | BRKRP | CAI |
|---|---|---|
| Dividend yield | 3.35% | N/A |
Growth (annualized)
| Metric | BRKRP | CAI |
|---|---|---|
| Revenue CAGR (5Y) | 9.10% | 26.15% |
| FCF CAGR (5Y) | -21.33% | N/A |
Frequently asked
- Which has grown faster, BRKRP or CAI?
- Over the past five years, CAI grew revenue faster — BRKRP at a 9.10% CAGR versus CAI at 26.15%.
- Does BRKRP or CAI pay a bigger dividend?
- BRKRP pays a dividend (3.35% yield), while CAI has no payments in the available dividend history.
- Is BRKRP or CAI more profitable?
- CAI runs the higher net margin — BRKRP at -2.03% versus CAI at 10.62%.
Go deeper
Dig into the metrics
Caris Life Sciences P/E ratioBruker dividend yieldBruker ROECaris Life Sciences ROEBruker operating marginCaris Life Sciences operating marginBruker revenue growthCaris Life Sciences revenue growthBruker free cash flowCaris Life Sciences free cash flow
Bruker & Caris Life Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.